KIT overexpression induces proliferation in astrocytes in an imatinib‐responsive manner and associates with proliferation index in gliomas
暂无分享,去创建一个
P. Kovanen | O. Jänne | K. Peltonen | H. Haapasalo | N. Nupponen | A. Angers-Loustau | M. Linja | L. Kerosuo | K. Wartiovaara | T. Blom | H. Fox
[1] J. Reis-Filho,et al. Molecular Alterations of KIT Oncogene in Gliomas , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[2] A. Paetau,et al. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in Gliomas , 2006, Molecular Cancer Research.
[3] C. Heldin,et al. Characterization of an imatinib-sensitive subset of high-grade human glioma cultures , 2006, Oncogene.
[4] J. Isola,et al. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival , 2006, Neuropathology and applied neurobiology.
[5] A. Paetau,et al. Molecular genetic analysis of the REST/NRSF gene in nervous system tumors , 2006, Acta Neuropathologica.
[6] A. Buschauer,et al. Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity , 2006, Journal of Cancer Research and Clinical Oncology.
[7] Jayant P. Menon,et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.
[8] L. Reber,et al. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. , 2006, European journal of pharmacology.
[9] Allan H Friedman,et al. Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] G. Dresemann. Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] H. Joensuu,et al. Amplification of genes encoding KIT, PDGFRα and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme , 2005, The Journal of pathology.
[12] Robin L. Jones,et al. The development and application of imatinib , 2005, Expert opinion on drug safety.
[13] K. Forsberg-Nilsson,et al. Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. , 2004, Experimental cell research.
[14] K. Jin,et al. Stem cell factor stimulates neurogenesis in vitro and in vivo. , 2002, The Journal of clinical investigation.
[15] Eric C. Holland,et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice , 2000, Nature Genetics.
[16] J. Tonn,et al. Matrix metalloproteinases and their biological function in human gliomas , 1999, International Journal of Developmental Neuroscience.
[17] Hannu,et al. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. , 1993, The American journal of pathology.
[18] K. Manova,et al. c-kit receptor and ligand expression in postnatal development of the mouse cerebellum suggests a function for c-kit in inhibitory interneurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[19] N. Copeland,et al. Embryonic RNA expression patterns of the c‐kit receptor and its cognate ligand suggest multiple functional roles in mouse development. , 1991, The EMBO journal.
[20] K. Franssila,et al. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] K. Welte,et al. Coexpression of stem cell factor and its receptor c-Kit in human malignant glioma cell lines , 2004, Acta Neuropathologica.
[22] Su-Chun Zhang,et al. Cellular localization of stem cell factor and c‐kit receptor in the mouse nervous system , 1997, Journal of neuroscience research.